Reveals how widening the boundaries of illness and lowering the threshold for treatments is creating millions of new patients and billions in new profits, in turn threatening to bankrupt national healthcare systems all over the world.
"synopsis" may belong to another edition of this title.
Ray Moynihan is one of the world's leading health writers. His work has appeared in the Sydney Morning Herald, The Age, the Australian Financial Review, the British Medical Journal, Lancet and New England Journal of Medicine. Alan Cassels is a Canadian researcher and writer who works on drug policy issues.
This accessible study about the collusion between medical science and the drug industry emphasizes how drug companies market their products by either redefining problems as diseases (like female sexual dysfunction) or redefining a condition to encompass a greater percentage of the population. Moynihan, a health journalist for the New England Journal of Medicine and the Lancet, and Cassels, a Canadian science writer, note, for instance, that eight of the nine specialists who wrote the 2004 federal guideline on high cholesterol, which substantially increased the number of people in that category, have multiple financial ties to drug manufacturers. Physicians now routinely prescribe cholesterol-lowering pills (statins) that may have perilous side effects, when many people could lower their risk of heart attack with less costly and dangerous steps, such as exercise and improved diet. Through aggressive merchandising, funding of medical conferences and expensive perks, drug companies win doctors over to diagnosing these "diseases" and prescribing drugs for them. Unfortunately for these authors, much of this territory has been covered by several books in the past year, most notably Marcia Angell's The Truth About the Drug Companies
Copyright © Reed Business Information, a division of Reed Elsevier Inc. All rights reserved.
"About this title" may belong to another edition of this title.
US$ 10.75 shipping from United Kingdom to U.S.A.
Destination, rates & speedsUS$ 13.44 shipping from United Kingdom to U.S.A.
Destination, rates & speedsSeller: Better World Books Ltd, Dunfermline, United Kingdom
Condition: Very Good. Ships from the UK. Former library book; may include library markings. Used book that is in excellent condition. May show signs of wear or have minor defects. Seller Inventory # GRP55514492
Quantity: 1 available
Seller: Anybook.com, Lincoln, United Kingdom
Condition: Fair. This is an ex-library book and may have the usual library/used-book markings inside.This book has soft covers. In fair condition, suitable as a study copy. Please note the Image in this listing is a stock photo and may not match the covers of the actual item,400grams, ISBN:9781741145793. Seller Inventory # 7087553
Quantity: 1 available
Seller: Anybook.com, Lincoln, United Kingdom
Condition: Fair. This is an ex-library book and may have the usual library/used-book markings inside.This book has soft covers. In fair condition, suitable as a study copy. Please note the Image in this listing is a stock photo and may not match the covers of the actual item,400grams, ISBN:9781741145793. Seller Inventory # 9796129
Quantity: 1 available
Seller: ThriftBooks-Atlanta, AUSTELL, GA, U.S.A.
Paperback. Condition: Good. No Jacket. Pages can have notes/highlighting. Spine may show signs of wear. ~ ThriftBooks: Read More, Spend Less 0.7. Seller Inventory # G1741145791I3N00
Quantity: 1 available
Seller: Revaluation Books, Exeter, United Kingdom
Paperback. Condition: Brand New. 274 pages. 8.19x5.35x0.94 inches. In Stock. Seller Inventory # zk1741145791
Quantity: 1 available